Overview
Junko Tanizaki practices in Osaka, Japan. Ms. Tanizaki is rated as a Distinguished expert by MediFind in the treatment of EGFR Positive Lung Cancer. Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Lung Cancer, and Lymphofollicular Hyperplasia.
Her clinical research consists of co-authoring 76 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 11 articles in the study of EGFR Positive Lung Cancer.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- EGFR Positive Lung CancerMs. Tanizaki isDistinguished. Learn about EGFR Positive Lung Cancer.
- Lung CancerMs. Tanizaki isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Ms. Tanizaki isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Experienced
- Acute PainMs. Tanizaki isExperienced. Learn about Acute Pain.
- AscitesMs. Tanizaki isExperienced. Learn about Ascites.
- Breast CancerMs. Tanizaki isExperienced. Learn about Breast Cancer.
- Extramammary Paget DiseaseMs. Tanizaki isExperienced. Learn about Extramammary Paget Disease.
- Lung AdenocarcinomaMs. Tanizaki isExperienced. Learn about Lung Adenocarcinoma.
- Lymphofollicular HyperplasiaMs. Tanizaki isExperienced. Learn about Lymphofollicular Hyperplasia.